Nervous system injury can have devastating long-term effects on brain or nerve function, yet signaling pathways that regulate nervous system responses to injury, especially in early acute phases, remain poorly defined. In our previous work we sought to identify molecules required to drive axon degeneration after axotomy and identified dSarm/Sarm1 as a key signaling molecule that drives axon auto-destruction. In dsarm/Sarm1 null mutant flies or mice, severed distal axons do not degenerate and remain morphologically intact for weeks after injury. Understanding how dSarm/Sarm1 signals in axons is now a major focus for the field, but the vast majority of studies have focused on the final outcome of axotomy?axonal degeneration?which occurs many hours to days after axotomy. In preliminary work we discovered that nerve injury leads to rapid changes (within 2-3 hrs after injury) in axon transport in both severed axons and adjacent intact neurons, and a suppression of sensory signal transduction in intact neurons throughout the nerve. We wish to understand how injury signals spread throughout the nerve so quickly to activate these response (which we refer to as Phase 1 responses), and the roles that neurons and glia play in this process. Interestingly, we found that components of the dSarm signaling pathway, the Ca2+-driven Unc-76?Cacophony?CamK-II?dSarm signaling pathway, and components of the MAPK pathway play important roles within 3 hrs after injury to alter axonal cell biology and function. In addition, we found that the glial receptor Draper/MEGF10, functions in glia to activate Phase 1 responses in intact neurons (but not severed neurons) within 3 hrs after injury.
In Aim 1 we will characterize this novel role for dSarm/Sarm1 and the axon death signaling machinery in regulation of early (Phase 1) responses in intact neurons and severed axons in a simple, genetically-tractable injured nerved, and how these signaling events alter neurophysiology.
In Aim 2 we will perform similar studies to explore a novel role for the Unc-76?Cacophony?CamK-II?dSarm signaling pathway and MAPK signaling in axonal Phase 1 responses to nerve injury.
In Aim 3 we will determine how nerve injury severity regulates neuronal and glial responses to injury, and how the Draper signaling pathway helps spread injury signals along a nerve to modulate nerve-wide changes in axon physiology. This work will provide important new insights into how axon death signaling molecules regulate acute responses to nerve injury, identify new molecules involved in injury signaling (Unc-76, Cacophony, CamK-II), clarify how MAPK signaling drives changes in axon biology after injury, and delineate exciting new roles for Draper/MEGF10 during the acute window of nerve responses to injury. Given that dSarm/Sarm1 and Draper/MEGF10 signaling pathways (and their functional roles) are highly conserved, our work will illuminate fundamental mechanisms of nervous system injury signaling that should have high relevance to human neural injury and neurological disease.

Public Health Relevance

Nervous system injury or disease results in the degeneration of neuronal fibers, connections in the brain are lost, and neural function is irreversibly compromised. How tissues and cells in the brain communicate with one another after injury to mediate these responses remains poorly defined, but we discovered a remarkable group of molecules that potently suppress many of the negative effects associated with brain after injury. The work in this proposal will define precisely how these molecules function to coordinate nervous system responses to injury, and should lead to the identification of exciting new candidates for therapeutic intervention in neurological disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS059991-11
Application #
9763955
Study Section
Neurodifferentiation, Plasticity, and Regeneration Study Section (NDPR)
Program Officer
Bambrick, Linda Louise
Project Start
2008-04-01
Project End
2024-02-29
Budget Start
2019-03-01
Budget End
2020-02-29
Support Year
11
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Oregon Health and Science University
Department
Neurosciences
Type
Overall Medical
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Francis, Michael M; Freeman, Marc R (2016) Dendrites actively restrain axon outgrowth and regeneration. Proc Natl Acad Sci U S A 113:5465-6
Sreedharan, Jemeen; Neukomm, Lukas J; Brown Jr, Robert H et al. (2015) Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2. Curr Biol 25:2130-6
Neukomm, Lukas J; Freeman, Marc R (2014) Diverse cellular and molecular modes of axon degeneration. Trends Cell Biol 24:515-23
Neukomm, Lukas J; Burdett, Thomas C; Gonzalez, Michael A et al. (2014) Rapid in vivo forward genetic approach for identifying axon death genes in Drosophila. Proc Natl Acad Sci U S A 111:9965-70
Freeman, Marc R (2014) Signaling mechanisms regulating Wallerian degeneration. Curr Opin Neurobiol 27:224-31
Rooney, Timothy M; Freeman, Marc R (2014) Drosophila models of neuronal injury. ILAR J 54:291-5
Milde, Stefan; Fox, A Nicole; Freeman, Marc R et al. (2013) Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo. Sci Rep 3:2567
Wishart, Thomas M; Rooney, Timothy M; Lamont, Douglas J et al. (2012) Combining comparative proteomics and molecular genetics uncovers regulators of synaptic and axonal stability and degeneration in vivo. PLoS Genet 8:e1002936
Avery, Michelle A; Rooney, Timothy M; Pandya, Jignesh D et al. (2012) WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr Biol 22:596-600
Osterloh, Jeannette M; Yang, Jing; Rooney, Timothy M et al. (2012) dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science 337:481-4

Showing the most recent 10 out of 13 publications